Corcept Therapeutics Incorporated (CORT)
NCM – Real Time Price. Currency in USD
51.16
-0.04 (-0.08%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
51.16
-0.04 (-0.08%)
At close: May 12, 2026, 4:00 PM EDT
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig’s disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.
| Name | Position |
|---|---|
| Dr. Hazel Hunt Ph.D. | Chief Scientific Officer |
| Dr. Joseph K. Belanoff M.D. | Co-Founder, President, CEO & Director |
| Dr. William Guyer Pharm.D. | Chief Development Officer |
| Mr. Atabak Mokari | CFO & Treasurer |
| Mr. Gary Charles Robb J.D. | Chief Business Officer & Secretary |
| Mr. Joseph Douglas Lyon | Chief Technology & Accounting Officer |
| Mr. Roberto W. Vieira | President of Oncology |
| Mr. Sean Maduck | President of Endocrinology |
| Ms. Amy Flood | Chief Human Resources & Communications Officer |
| Ms. Monica Tellado | President of Emerging Markets |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | 8-K | cort-20260430.htm |
| 2026-04-17 | DEF 14A | cort-20260417.htm |
| 2026-03-25 | 8-K | d123475d8k.htm |
| 2026-02-24 | 10-K | cort-20251231.htm |
| 2026-02-19 | 8-K | d25779d8k.htm |
| 2026-01-22 | 8-K | d96058d8k.htm |
| 2025-12-31 | 8-K | d50993d8k.htm |
| 2025-11-04 | 8-K | cort-20251104.htm |
| 2025-11-04 | 10-Q | cort-20250930.htm |
| 2025-10-14 | 8-K | d61706d8k.htm |